Edwin Zhang
Stock Analyst at HC Wainwright & Co.
(1.33)
# 2,236
Out of 4,479 analysts
9
Total ratings
44.44%
Success rate
7.32%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CALT Calliditas Therapeutics AB (publ) | Reiterates: Buy | $50 | $38.75 | +29.03% | 4 | Oct 16, 2023 | |
| RPHM Reneo Pharmaceuticals | Initiates: Buy | $28 | $1.51 | +1,754.30% | 1 | Dec 21, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Buy | n/a | $40.96 | - | 1 | Sep 30, 2021 | |
| LOGC ContextLogic | Initiates: Buy | n/a | $5.67 | - | 1 | Jun 7, 2021 | |
| FGEN FibroGen | Downgrades: Neutral | n/a | $0.74 | - | 1 | Apr 7, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | n/a | $3.25 | - | 1 | Feb 8, 2021 |
Calliditas Therapeutics AB (publ)
Oct 16, 2023
Reiterates: Buy
Price Target: $50
Current: $38.75
Upside: +29.03%
Reneo Pharmaceuticals
Dec 21, 2021
Initiates: Buy
Price Target: $28
Current: $1.51
Upside: +1,754.30%
Ultragenyx Pharmaceutical
Sep 30, 2021
Initiates: Buy
Price Target: n/a
Current: $40.96
Upside: -
ContextLogic
Jun 7, 2021
Initiates: Buy
Price Target: n/a
Current: $5.67
Upside: -
FibroGen
Apr 7, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.74
Upside: -
Aldeyra Therapeutics
Feb 8, 2021
Initiates: Buy
Price Target: n/a
Current: $3.25
Upside: -